Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 270670, 32 pages
http://dx.doi.org/10.1155/2012/270670
Review Article

Possible Roles of Proinflammatory and Chemoattractive Cytokines Produced by Human Fetal Membrane Cells in the Pathology of Adverse Pregnancy Outcomes Associated with Influenza Virus Infection

1Department of Clinical Molecular Genetics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
2Yoneyama Maternity Hospital, 2-12 Shin-machi, Hachioji, Tokyo 192-0065, Japan

Received 16 January 2012; Accepted 27 April 2012

Academic Editor: Felipe Vadillo-Ortega

Copyright © 2012 Noboru Uchide et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Horimoto and T. Kawaoka, “Pandemic influenza,” The Open Antimicrobial Agents Journal, vol. 2, no. 1, pp. 9–14, 2010. View at Google Scholar
  2. The World Health Organization, “What is post-pandemic,” Global Alert and Response, 2010, http://www.who.int/csr/disease/swineflu/frequently_asked_questions/post_pandemic/en/.
  3. The World Health Organization, “Standardization of terminology of the pandemic A(H1N1)2009 virus,” 2011, http://www.who.int/influenza/gisrs_laboratory/terminology_ah1n1pdm09/en/.
  4. L. Dodds, S. A. McNeil, D. B. Fell et al., “Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women,” Canadian Medical Association Journal, vol. 176, no. 4, pp. 463–468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. V. Hartert, K. M. Neuzil, A. K. Shintani et al., “Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season,” American Journal of Obstetrics and Gynecology, vol. 189, no. 6, pp. 1705–1712, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Neuzil, G. W. Reed, E. F. Mitchel, L. Simonsen, and M. R. Griffin, “Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women,” American Journal of Epidemiology, vol. 148, no. 11, pp. 1094–1102, 1998. View at Google Scholar · View at Scopus
  7. D. W. Freeman and A. Barno, “Deaths from Asian influenza associated with pregnancy,” American Journal of Obstetrics and Gynecology, vol. 78, pp. 1172–1175, 1959. View at Google Scholar · View at Scopus
  8. M. Greenberg, H. Jacobziner, J. Pakter, and B. A. Weisl, “Maternal mortality in the epidemic of Asian influenza, New York City, 1957,” American Journal of Obstetrics and Gynecology, vol. 76, no. 4, pp. 897–902, 1958. View at Google Scholar
  9. J. M. Hardy, E. N. Azarowicz, A. Mannini, D. N. Medearis, and R. E. Cooke, “The effect of Asian influenza on the outcome of pregnancy, Baltimore,,” American Journal of Public Health and the Nation's Health, vol. 51, pp. 1182–1188, 1961. View at Google Scholar · View at Scopus
  10. J. W. Harris, “Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases,” The Journal of the American Medical Association, vol. 72, no. 14, pp. 978–980, 1919. View at Google Scholar
  11. A. D. McDonald, “Maternal health in early pregnancy and congenital defect. Final report on a prospective inquiry,” British Journal of Preventive and Social Medicine, vol. 15, pp. 154–166, 1961. View at Google Scholar
  12. D. J. Jamieson, S. A. Rasmussen, T. M. Uyeki, and C. Weinbaum, “Pandemic influenza and pregnancy revisited: lessons learned from 2009 pandemic influenza A (H1N1),” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, pp. S1–S3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Rasmussen, D. M. Kissin, L. F. Yeung et al., “Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S13–S20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. G. Mosby, S. A. Rasmussen, and D. J. Jamieson, “2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature,” American Journal of Obstetrics and Gynecology, vol. 205, no. 1, pp. 10–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System, “Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study,” British Medical Journal, vol. 340, article c1279, 2010. View at Google Scholar · View at Scopus
  16. A. Campbell, R. Rodin, R. Kropp et al., “Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza,” Canadian Medical Association Journal, vol. 182, no. 4, pp. 349–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Creanga, T. F. Johnson, S. B. Graitcer et al., “Severity of 2009 pandemic influenza a (H1N1) virus infection in pregnant women,” Obstetrics and Gynecology, vol. 115, no. 4, pp. 717–726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Fuhrman, I. Bonmarin, A. C. Paty et al., “Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009,” Euro Surveillance, vol. 15, no. 2, Article ID pii: 19463, 2010. View at Google Scholar · View at Scopus
  19. P. Gérardin, R. El Amrani, B. Cyrille et al., “Low clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La Réunion,” PloS ONE, vol. 5, no. 5, Article ID e10896, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Hanslik, P. Y. Boelle, and A. Flahault, “Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009–2010,” PLoS Currents, vol. 2, Article ID RRN1150, 2010. View at Google Scholar
  21. D. J. Jamieson, M. A. Honein, S. A. Rasmussen et al., “H1N1 2009 influenza virus infection during pregnancy in the USA,” The Lancet, vol. 374, no. 9688, pp. 451–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kelly, G. Mercer, and A. Cheng, “Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009,” Euro Surveillance, vol. 14, no. 50, Article ID pii: 19441, 2009. View at Google Scholar · View at Scopus
  23. C. F. N. Koegelenberg, E. M. Irusen, R. Cooper et al., “High mortality from respiratory failure secondary to swine-origin influenza a (H1N1) in south africa,” QJM, vol. 103, no. 5, Article ID hcq022, pp. 319–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. New South Wales public health network, “Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia,” Euro Surveillance, vol. 14, no. 42, Article ID pii 19365, 2009. View at Google Scholar · View at Scopus
  25. W. Oliveira, E. Carmo, G. Penna et al., “Pandemic H1N1 influenza in Brazil: analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI),” Euro Surveillance, vol. 14, no. 42, Article ID pii: 19362, 2009. View at Google Scholar · View at Scopus
  26. P. Yang, Y. Deng, X. Pang et al., “Severe, critical and fatal cases of 2009 H1N1 influenza in China,” Journal of Infection, vol. 61, no. 4, pp. 277–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Zarychanski, T. L. Stuart, A. Kumar et al., “Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection,” Canadian Medical Association Journal, vol. 182, no. 3, pp. 257–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. T. S. Kwan-Gett, A. Baer, and J. S. Duchin, “Spring 2009 H1N1 influenza outbreak in King Country Washington,” Disaster Medicine and Public Health Preparedness, vol. 3, no. 2, pp. S109–S116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. K. Louie, M. Acosta, D. J. Jamieson, and M. A. Honein, “Severe 2009 H1N1 influenza in pregnant and postpartum women in California,” The New England Journal of Medicine, vol. 362, no. 1, pp. 27–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Siston, S. A. Rasmussen, M. A. Honein et al., “Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States,” Journal of the American Medical Association, vol. 303, no. 15, pp. 1517–1525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Yates, M. Pierce, S. Stephens et al., “Influenza A/HINIv in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant,” Health Technology Assessment, vol. 14, no. 34, pp. 109–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Centers for Disease Control and Prevention (CDC), “2009 pandemic influenza a (H1N1) in pregnant women requiring intensive care—New York City, 2009,” Morbidity and Mortality Weekly Report, vol. 59, no. 11, pp. 321–326, 2010. View at Google Scholar · View at Scopus
  33. A. C. Miller, F. Safi, S. Hussain, R. A. Subramanian, E. M. Elamin, and R. Sinert, “Novel influenza A(H1N1) virus among gravid admissions,” Archives of Internal Medicine, vol. 170, no. 10, pp. 868–873, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hewagama, S. P. Walker, R. L. Stuart et al., “2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia,” Clinical Infectious Diseases, vol. 50, no. 5, pp. 686–690, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. L. Lim, W. Y. Lim, N. W. S. Tee, S. H. Lim, and J. J. Chee, “Obstetric outcomes of influenza a H1N1 (2009) infection in pregnancy—experience of a Singapore tertiary hospital,” Annals of the Academy of Medicine Singapore, vol. 39, no. 4, pp. 295–298, 2010. View at Google Scholar · View at Scopus
  36. B. Honarvar, N. Asadi, F. Ghaffarpasand, M. Moghadami, and M. Kasraeian, “Pregnancy outcomes among patients infected with pandemic H1N1 influenza virus in Shiraz, Iran,” International Journal of Gynecology and Obstetrics, vol. 111, no. 1, pp. 86–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Pierce, J. J. Kurinczuk, P. Spark, P. Brocklehurst, and M. Knight, “Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study,” British Medical Journal, vol. 342, no. 7811, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Pramanick, S. Rathore, J. V. Peter, M. Moorthy, and J. Lionel, “Pandemic (H1N1) 2009 virus infection during pregnancy in South India,” International Journal of Gynecology and Obstetrics, vol. 113, no. 1, pp. 32–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Nakai, H. Minakami, N. Unno et al., “Characteristics of pregnant Japanese women who required hospitalization for treatment of pandemic (H1N1) 2009—low mortality rate may be due to early antiviral use,” Journal of Infection, vol. 62, no. 3, pp. 232–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. E. A. Figueiró-Filho, M. L. G. Oliveira, M. A. Pompilio et al., “Obstetric, clinical, and perinatal implications of H1N1 viral infection during pregnancy,” International Journal of Gynecology and Obstetrics, vol. 116, no. 3, pp. 214–218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. Ş. Özyer, S. Ünlü, S. Çelen et al., “Pandemic influenza H1N1 2009 virus infection in pregnancy in Turkey,” Taiwanese Journal of Obstetrics and Gynecology, vol. 50, no. 3, pp. 312–317, 2011. View at Google Scholar · View at Scopus
  42. T. Oluyomi-Obi, L. Avery, C. Schneider et al., “Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A,” Journal of Obstetrics and Gynaecology Canada, vol. 32, no. 5, pp. 443–452, 2010. View at Google Scholar · View at Scopus
  43. A. A. Creanga, L. Kamimoto, K. Newsome et al., “Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S38–S45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. R. Ellington, L. K. Hartman, M. Acosta et al., “Pandemic 2009 influenza A (H1N1) in 71 critically ill pregnant women in California,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, pp. S21–S30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Gozde Kanmaz, O. Erdeve, S. Suna Oĝz et al., “Placental transmission of novel pandemic influenza a virus,” Fetal and Pediatric Pathology, vol. 30, no. 5, pp. 280–285, 2011. View at Google Scholar · View at Scopus
  46. M. Djibré, N. Berkane, A. Salengro et al., “Non-invasive management of acute respiratory distress syndrome related to Influenza A (H1N1) virus pneumonia in a pregnant woman,” Intensive Care Medicine, vol. 36, no. 2, pp. 373–374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Kaufman, G. J. Duke, F. McGain et al., “Life-threatening respiratory failure from H1N1 influenza 09 (human swine influenza),” Medical Journal of Australia, vol. 191, no. 3, pp. 154–156, 2009. View at Google Scholar · View at Scopus
  48. D. Fridman, O. Kuzbari, and H. Minkoff, “Novel influenza H1N1 in pregnancy: a report of two cases,” Infectious Diseases in Obstetrics and Gynecology, vol. 2009, Article ID 514353, 3 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M. E. Lum, A. J. McMillan, C. W. Brook, R. Lester, and L. S. Piers, “Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria,” Medical Journal of Australia, vol. 191, no. 9, pp. 502–506, 2009. View at Google Scholar · View at Scopus
  50. A. Jafari, E. S. Langen, N. Aziz, Y. J. Blumenfeld, F. Mihm, and M. L. Druzin, “The effects of respiratory failure on delivery in pregnant patients with H1N1 2009 influenza,” Obstetrics and Gynecology, vol. 115, no. 5, pp. 1033–1035, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Scriven, R. McEwen, S. Mistry et al., “Swine flu: a Birmingham experience,” Clinical Medicine, Journal of the Royal College of Physicians of London, vol. 9, no. 6, pp. 534–538, 2009. View at Google Scholar · View at Scopus
  52. A. O'Dowd, “Swine flu claims first European death, as cases worldwide rise to 36,000,” British Medical Journal, vol. 338, Article ID b2470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. M. F. Jiménez, P. El Beitune, M. P. Salcedo, A. V. Von Ameln, F. P. Mastalir, and L. D. Braun, “Outcomes for pregnant women infected with the influenza A (H1N1) virus during the 2009 pandemic in Porto Alegre, Brazil,” International Journal of Gynecology and Obstetrics, vol. 111, no. 3, pp. 217–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. Government of Western Australia Department of Health, “Guidelines for the Obstetric and Neonatal specialist services for the management of Influenza-like illness during the influenza pandemic associated with the influenza A (H1N1) 2009 virus,” pp. 1–7, 2009. View at Google Scholar
  55. M. D. Parkins, K. Fonseca, A. D. Peets, K. B. Laupland, K. Shamseddin, and M. J. Gill, “A potentially preventable case of serious influenza infection in a pregnant patient,” Canadian Medical Association Journal, vol. 177, no. 8, pp. 851–853, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Dulyachai, J. Makkoch, P. Rianthavorn et al., “Perinatal pandemic (H1N1) 2009 infection, Thailand,” Emerging Infectious Diseases, vol. 16, no. 2, pp. 343–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Valvi, R. Kulkarni, A. Kinikar, and S. Khadse, “2009H1N1 Infection in a 1-day-old neonate,” Indian Journal of Medical Sciences, vol. 64, no. 12, pp. 549–552, 2010. View at Google Scholar · View at Scopus
  58. R. D. Vásquez, V. M. Chávez, I. E. Gamio et al., “Probable vertical transmission of the influenza virus a (H1N1): apropos of a case,” Revista Peruana de Medicina de Experimental y Salud Publica, vol. 27, no. 3, pp. 466–469, 2010. View at Google Scholar · View at Scopus
  59. M. Cetinkaya, H. Ozkan, S. Celebi, N. Köksal, and M. Hacimustafaoğlu, “Human 2009 influenza A (H1N1) virus infection in a premature infant born to an H1N1–infected mother: placental transmission?” The Turkish Journal of Pediatrics, vol. 53, no. 4, pp. 441–444, 2011. View at Google Scholar
  60. M. Oughton, A. Dascal, D. Laporta, H. Charest, M. Afilalo, and M. Miller, “Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09,” Diagnostic Microbiology and Infectious Disease, vol. 70, no. 2, pp. 213–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Tse, K. K. W. To, X. Wen et al., “Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection,” PloS ONE, vol. 6, no. 9, Article ID e22534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. P. T. Conover and U. Roessmann, “Malformational complex in an infant with intrauterine influenza viral infection,” Archives of Pathology and Laboratory Medicine, vol. 114, no. 5, pp. 535–538, 1990. View at Google Scholar · View at Scopus
  63. J. F. Jewett, “Influenza pneumonia at term,” The New England Journal of Medicine, vol. 291, no. 5, pp. 256–257, 1974. View at Google Scholar · View at Scopus
  64. D. H. Yawn, J. C. Pyeatte, J. M. Joseph, S. L. Eichler, and R. Garcia-Bunuel, “Transplacental transfer of influenza virus,” Journal of the American Medical Association, vol. 216, no. 6, pp. 1022–1023, 1971. View at Publisher · View at Google Scholar · View at Scopus
  65. J. A. McGregor, J. C. Burns, and M. J. Levin, “Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome,” American Journal of Obstetrics and Gynecology, vol. 149, no. 8, pp. 856–859, 1984. View at Google Scholar · View at Scopus
  66. V. F. Mel'nikova, A. V. Tsinzerling, O. A. Aksenov, S. P. Vydumkina, and N. A. Kalinina, “Involvement of the afterbirth in influenza,” Arkhiv Patologii, vol. 49, no. 9, pp. 19–25, 1987. View at Google Scholar · View at Scopus
  67. A. V. Zinserling, O. A. Arksenov, V. F. Melnikova, and V. A. Zinserling, “Extrapulmonary lesions in influenza,” Tohoku Journal of Experimental Medicine, vol. 140, no. 3, pp. 259–272, 1983. View at Google Scholar · View at Scopus
  68. J. Gu, Z. Xie, Z. Gao et al., “H5N1 infection of the respiratory tract and beyond: a molecular pathology study,” The Lancet, vol. 370, no. 9593, pp. 1137–1145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Yao, C. Korteweg, W. Hsueh, and J. Gu, “Avian influenza receptor expression in H5N1-infected and noninfected human tissues,” The FASEB Journal, vol. 22, no. 3, pp. 733–740, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. F. L. Ruben, A. Winkelstein, and R. E. Sabbagha, “In utero sensitization with influenza virus in man,” Proceedings of the Society for Experimental Biology and Medicine, vol. 149, no. 4, pp. 881–883, 1975. View at Google Scholar · View at Scopus
  71. F. L. Ruben and D. S. Thompson, “Cord blood lymphocyte in vitro responses to influenza A antigens after an epidemic of influenza A/Port Chalmers/73 (H3N2),” American Journal of Obstetrics and Gynecology, vol. 141, no. 4, pp. 443–447, 1981. View at Google Scholar · View at Scopus
  72. G. R. G. Monif, D. L. Sowards, and D. V. Eitzman, “Serologic and immunologic evaluation of neonates following maternal influenza infection during the second and third trimesters of gestation,” American Journal of Obstetrics and Gynecology, vol. 114, no. 2, pp. 239–242, 1972. View at Google Scholar · View at Scopus
  73. A. M. Likos, D. J. Kelvin, C. M. Cameron, T. Rowe, M. J. Kuehnert, and P. J. Norris, “Influenza viremia and the potential for blood-borne transmission,” Transfusion, vol. 47, no. 6, pp. 1080–1088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. R. W. Lieberman, N. Bagdasarian, D. Thomas, and C. Van De Ven, “Seasonal influenza A (H1N1) infection in early pregnancy and second trimester fetal demise,” Emerging Infectious Diseases, vol. 17, no. 1, pp. 107–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. S. A. Rasmussen, E. B. Hayes, D. J. Jamieson, and D. R. O'Leary, “Emerging infections and pregnancy: assessing the impact on the embryo or fetus,” American Journal of Medical Genetics A, vol. 143, no. 24, pp. 2896–2903, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Xu, L. Bao, W. Deng, and C. Qin, “Highly pathogenic avian influenza H5N1 virus could partly be evacuated by pregnant BALB/c mouse during abortion or preterm delivery,” Virology Journal, vol. 8, article 342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. J. P. Lavery, “Appendages of the placenta,” in The Human Placenta, J. P. Lavery, Ed., pp. 257–279, Aspen Publishers, Maryland, Australia, 1987. View at Google Scholar
  78. T. M. Malak and S. C. Bell, “Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site,” British Journal of Obstetrics and Gynaecology, vol. 101, no. 5, pp. 375–386, 1994. View at Google Scholar · View at Scopus
  79. S. Parry and J. F. Strauss, “Premature rupture of the fetal membranes,” The New England Journal of Medicine, vol. 338, no. 10, pp. 663–670, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. S. S. Kim, R. Romero, J. S. Kim et al., “Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo plasticity of chorioamniotic mesodermal cells of the human placenta,” Laboratory Investigation, vol. 88, no. 4, pp. 365–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. J. H. Grossman and L. G. Dennis, “Infections affecting the placenta,” in The Human Placenta, J. P. Lavery, Ed., pp. 131–154, Aspen Publishers, Md , USA, 1987. View at Google Scholar
  82. R. Menon and S. J. Fortunato, “The role of matrix degrading enzymes and apoptosis in rupture of membranes,” Journal of the Society for Gynecologic Investigation, vol. 11, no. 7, pp. 427–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. R. M. Moore, J. M. Mansour, R. W. Redline, B. M. Mercer, and J. J. Moore, “The physiology of fetal membrane rupture: insight gained from the determination of physical properties,” Placenta, vol. 27, no. 11-12, pp. 1037–1051, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. M. H. F. Sullivan, “Matrix metalloproteinases, in Molecular and Cell Biology,” in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 31–41, Research Signpost, Kerala, India, 2012. View at Google Scholar
  85. F. Vadillo-Ortega and G. Estrada-Gutiérrez, “Role of matrix metalloproteinases in preterm labour,” An International Journal of Obstetrics and Gynaecology, vol. 112, no. 1, supplement s1, pp. 19–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. R. Menon, “Apoptosis: a decisive factor associated with preterm premature rupture of membranes,” in Molecular and Cell Biology in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 43–60, Research Signpost, Kerala, India, 2012. View at Google Scholar
  87. B. Yuan, K. Ohyama, N. Uchide, T. Bessho, M. Takeichi, and H. Toyoda, “Reactive oxygen species,” in Molecular and Cell Biology in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 43–60, Research Signpost, Kerala, India, 2012. View at Google Scholar
  88. M. N. Bou-Resli, N. S. Al-Zaid, and M. E. A. Ibrahim, “Full-term and prematurely ruptured fetal membranes. An ultrastructural study,” Cell and Tissue Research, vol. 220, no. 2, pp. 263–278, 1981. View at Google Scholar · View at Scopus
  89. T. H. Parmley, “Spontaneous cell death in the chorion laeve,” American Journal of Obstetrics and Gynecology, vol. 162, no. 6, pp. 1576–1583, 1990. View at Google Scholar · View at Scopus
  90. R. Runić, C. J. Lockwood, L. Lachapelle et al., “Apoptosis and Fas expression in human fetal membranes,” The Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 2, pp. 660–666, 1998. View at Publisher · View at Google Scholar · View at Scopus
  91. J. McLaren, D. J. Taylor, and S. C. Bell, “Increased incidence of apoptosis in non-labour-affected cytotrophoblast cells in term fetal membranes overlying the cervix,” Human Reproduction, vol. 14, no. 11, pp. 2895–2900, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. A. P. Murtha, R. Auten, and W. N. P. Herbert, “Apoptosis in the chorion laeve of term patients with histologic chorioamnionitis,” Infectious Diseases in Obstetrics and Gynecology, vol. 10, no. 2, pp. 93–96, 2002. View at Google Scholar · View at Scopus
  93. R. B. George, J. Kalich, B. Yonish, and A. P. Murtha, “Apoptosis in the chorion of fetal membranes in preterm premature rupture of membranes,” American Journal of Perinatology, vol. 25, no. 1, pp. 29–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Kumagai, Y. Otsuki, Y. Ito, M. A. Shibata, H. Abe, and M. Ueki, “Apoptosis in the normal human amnion at term, independent of Bcl-2 regulation and onset of labour,” Molecular Human Reproduction, vol. 7, no. 7, pp. 681–689, 2001. View at Google Scholar · View at Scopus
  95. K. Ohyama, K. Oka, A. Emura et al., “Suppression of apoptotic cell death progressed in vitro with incubation of the chorion laeve tissues of human fetal membrane by glucocorticoid,” Biological and Pharmaceutical Bulletin, vol. 21, no. 10, pp. 1024–1029, 1998. View at Google Scholar · View at Scopus
  96. K. Ohyama, B. Yuan, T. Bessho, and T. Yamakawa, “Progressive apoptosis in chorion laeve trophoblast cells of human fetal membrane tissues during in vitro incubation is suppressed by antioxidative reagents,” European Journal of Biochemistry, vol. 268, no. 23, pp. 6182–6189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. B. Yuan, K. Ohyama, T. Bessho, and H. Toyoda, “Contribution of inducible nitric oxide synthase and cyclooxygenase-2 to apoptosis induction in smooth chorion trophoblast cells of human fetal membrane tissues,” Biochemical and Biophysical Research Communications, vol. 341, no. 3, pp. 822–827, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. L. Virág, É. Szabó, P. Gergely, and C. Szabó, “Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention,” Toxicology Letters, vol. 140-141, pp. 113–124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. M. G. Salgo and W. A. Pryor, “Trolox inhibits peroxynitrite-mediated oxidative stress and apoptosis in rat thymocytes,” Archives of Biochemistry and Biophysics, vol. 333, no. 2, pp. 482–488, 1996. View at Publisher · View at Google Scholar · View at Scopus
  100. T. A. Swierkosz, J. A. Mitchell, T. D. Warner, R. M. Botting, and J. R. Vane, “Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids,” British Journal of Pharmacology, vol. 114, no. 7, pp. 1335–1342, 1995. View at Google Scholar · View at Scopus
  101. B. Yuan, K. Ohyama, T. Bessho, N. Uchide, and H. Toyoda, “Imbalance between ROS production and elimination results in apoptosis induction in primary smooth chorion trophoblast cells prepared from human fetal membrane tissues,” Life Sciences, vol. 82, no. 11-12, pp. 623–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. B. Yuan, K. Ohyama, M. Takeichi, and H. Toyoda, “Direct contribution of inducible nitric oxide synthase expression to apoptosis induction in primary smooth chorion trophoblast cells of human fetal membrane tissues,” The International Journal of Biochemistry and Cell Biology, vol. 41, no. 5, pp. 1062–1069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. F. Vadillo-Ortega, G. Gonzalez-Avila, E. E. Furth et al., “92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor,” American Journal of Pathology, vol. 146, no. 1, pp. 148–156, 1995. View at Google Scholar · View at Scopus
  104. X. Qin, P. K. Chua, R. H. Ohira, and G. D. Bryant-Greenwood, “An autocrine/paracrine role of human decidual relaxin. II. Stromelysin- 1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1),” Biology of Reproduction, vol. 56, no. 4, pp. 812–820, 1997. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Lappas and G. E. Rice, “The role and regulation of the nuclear factor kappa b signalling pathway in human labour,” Placenta, vol. 28, no. 5-6, pp. 543–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. I. A. Buhimschi, W. B. Kramer, C. S. Buhimschi, L. P. Thompson, and C. P. Weiner, “Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes,” American Journal of Obstetrics and Gynecology, vol. 182, no. 2, pp. 458–464, 2000. View at Google Scholar · View at Scopus
  107. M. Lappas, M. Permezel, and G. E. Rice, “N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1723–1729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. R. Romero, D. T. Brody, E. Oyarzun et al., “Infection and labor. III. Interleukin-1: a signal for the onset of parturition,” American Journal of Obstetrics and Gynecology, vol. 160, no. 5, pp. 1117–1123, 1989. View at Google Scholar · View at Scopus
  109. R. Romero, C. Avila, U. Santhanam, and P. B. Sehgal, “Amniotic fluid interleukin 6 in preterm labor. Association with infection,” Journal of Clinical Investigation, vol. 85, no. 5, pp. 1392–1399, 1990. View at Google Scholar · View at Scopus
  110. R. Romero, M. Mazor, W. Sepulveda, C. Avila, D. Copeland, and J. Williams, “Tumor necrosis factor in preterm and term labor,” American Journal of Obstetrics and Gynecology, vol. 166, no. 5, pp. 1576–1587, 1992. View at Google Scholar · View at Scopus
  111. R. Romero and B. Tartakovsky, “The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice,” American Journal of Obstetrics and Gynecology, vol. 167, no. 4, pp. 1041–1045, 1992. View at Google Scholar · View at Scopus
  112. P. C. Arck, M. Rose, K. Hertwig, E. Hagen, M. Hildebrandt, and B. F. Klapp, “Stress and immune mediators in miscarriage,” Human Reproduction, vol. 16, no. 7, pp. 1505–1511, 2001. View at Google Scholar · View at Scopus
  113. P. C. Arck, A. B. Troutt, and D. A. Clark, “Soluble receptors neutralizing TNF-α and IL-1 block stress-triggered murine abortion,” American Journal of Reproductive Immunology, vol. 37, no. 3, pp. 262–266, 1997. View at Google Scholar · View at Scopus
  114. R. J. A. Helliwell, L. F. Adams, and M. D. Mitchell, “Prostaglandin synthases: recent developments and a novel hypothesis,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 70, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. V. Zaga-Clavellina, G. Garcia-Lopez, H. Flores-Herrera et al., “In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes,” Reproductive Biology and Endocrinology, vol. 5, article 46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. V. Zaga, G. Estrada-Gutierrez, J. Beltran-Montoya, R. Maida-Claros, R. Lopez-Vancell, and F. Vadillo-Ortega, “Secretions of interleukin-1β and tumor necrosis factor α by whole fetal membranes depend on initial interactions of amnion or choriodecidua with lipopolysaccharides or group B streptococci,” Biology of Reproduction, vol. 71, no. 4, pp. 1296–1302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  117. R. Aaltonen, J. Heikkinen, T. Vahlberg, J. S. Jensen, and A. Alanen, “Local inflammatory response in choriodecidua induced by Ureaplasma urealyticum,” An International Journal of Obstetrics and Gynaecology, vol. 114, no. 11, pp. 1432–1435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. E. Paradowska, Z. Blach-Olszewska, and E. Gejdel, “Constitutive and induced cytokine production by human placenta and amniotic membrane at term,” Placenta, vol. 18, no. 5-6, pp. 441–446, 1997. View at Publisher · View at Google Scholar · View at Scopus
  119. N. Uchide, K. Ohyama, T. Bessho, and H. Toyoda, “Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection,” Medical Science Monitor, vol. 11, no. 1, pp. RA7–RA16, 2005. View at Google Scholar · View at Scopus
  120. N. Uchide, K. Ohyama, B. Yuan, T. Bessho, M. Takeichi, and H. Toyoda, “Macrophage activation,” in Molecular and Cell Biology in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 133–199, Research Signpost, Kerala, India, 2012. View at Google Scholar
  121. D. Kumar, R. M. Moore, B. M. Mercer, J. M. Mansour, R. W. Redline, and J. J. Moore, “Role of cytokines in biophysical weakening and rupture of human fetal membranes,” in Molecular and Cell Biology in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 61–88, Research Signpost, Kerala, India, 2012. View at Google Scholar
  122. J. M. Bowen, L. Chamley, M. D. Mitchell, and J. A. Keelan, “Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women,” Placenta, vol. 23, no. 4, pp. 239–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  123. J. M. Bowen, L. Chamley, J. A. Keelan, and M. D. Mitchell, “Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition,” Placenta, vol. 23, no. 4, pp. 257–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  124. N. Gomez-Lopez, G. Estrada-Gutierrez, L. Jimenez-Zamudio, R. Vega-Sanchez, and F. Vadillo-Ortega, “Fetal membranes exhibit selective leukocyte chemotaxic activity during human labor,” Journal of Reproductive Immunology, vol. 80, no. 1-2, pp. 122–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. N. Gomez-Lopez, E. Laresgoiti-Servitje, D. M. Olson, G. Estrada-Gutiérrez, and F. Vadillo-Ortega, “The role of chemokines in term and premature rupture of the fetal membranes: a review,” Biology of Reproduction, vol. 82, no. 5, pp. 809–814, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. F. C. Denison, R. W. Kelly, A. A. Calder, and S. C. Riley, “Cytokine secretion by human fetal membranes, decidua and placenta at term,” Human Reproduction, vol. 13, no. 12, pp. 3560–3565, 1998. View at Publisher · View at Google Scholar · View at Scopus
  127. J. A. Keelan, J. Yang, R. J. Romero et al., “Epithelial cell-derived neutrophil-activating peptide-78 is present in fetal membranes and amniotic fluid at increased concentrations with intra-amniotic infection and preterm delivery,” Biology of Reproduction, vol. 70, no. 1, pp. 253–259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. M. L. Casey, S. M. Cox, R. A. Word, and P. C. MacDonald, “Cytokines and infection-induced preterm labour,” Reproduction, Fertility and Development, vol. 2, no. 5, pp. 499–509, 1990. View at Google Scholar · View at Scopus
  129. R. Romero, J. Espinoza, L. F. Gonçalves, J. P. Kusanovic, L. Friel, and S. Hassan, “The role of inflammation and infection in preterm birth,” Seminars in Reproductive Medicine, vol. 25, no. 1, pp. 21–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. F. Saji, Y. Samejima, S. Kamiura, K. Sawai, K. Shimoya, and T. Kimura, “Cytokine production in chorioamnionitis,” Journal of Reproductive Immunology, vol. 47, no. 2, pp. 185–196, 2000. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Patni, P. Flynn, L. P. Wynen et al., “An introduction to Toll-like receptors and their possible role in the initiation of labour,” An International Journal of Obstetrics and Gynaecology, vol. 114, no. 11, pp. 1326–1334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. M. Kim, R. Romero, T. Chaiworapongsa et al., “Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis,” American Journal of Obstetrics and Gynecology, vol. 191, no. 4, pp. 1346–1355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  133. S. J. Choi, S.-H. Jung, M. Eom, K. H. Han, I.-B. Chung, and S.-K. Kim, “Immunohistochemical distribution of toll-like receptor 4 in preterm human fetal membrane,” Journal of Obstetrics and Gynaecology Research, vol. 38, no. 1, pp. 108–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. C. Gillaux, C. Méhats, D. Vaiman, D. Cabrol, and M. Breuiller-Fouché, “Functional screening of TLRs in human amniotic epithelial cells,” The Journal of Immunology, vol. 187, no. 5, pp. 2766–2774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Katsura, A. Ito, S. Hirakawa, and Y. Mori, “Human recombinant interleukin-1α increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells,” FEBS Letters, vol. 244, no. 2, pp. 315–318, 1989. View at Publisher · View at Google Scholar · View at Scopus
  136. M. D. Mitchell, D. J. Dudley, S. S. Edwin, and S. L. Schiller, “Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells,” European Journal of Pharmacology, vol. 192, no. 1, pp. 189–191, 1991. View at Publisher · View at Google Scholar · View at Scopus
  137. Y. Mano, K. Shibata, S. Sumigama et al., “Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes,” Gynecologic and Obstetric Investigation, vol. 68, no. 3, pp. 145–153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. T. So, A. Ito, T. Sato, Y. Mori, and S. Hirakawa, “Tumor necrosis factor-α stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells,” Biology of Reproduction, vol. 46, no. 5, pp. 772–778, 1992. View at Google Scholar · View at Scopus
  139. M. Blumenstein, W. R. Hansen, D. Deval, and M. D. Mitchell, “Differential regulation in human amnion epithelial and fibroblast cells of prostaglandin E2 production and prostaglandin H synthase-2 mRNA expression by dexamethasone but not tumour necrosis factor-α,” Placenta, vol. 21, no. 2-3, pp. 210–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  140. M. J. Leroy, E. Dallot, I. Czerkiewicz, T. Schmitz, and M. Breuiller-Fouché, “Inflammation of choriodecidua induces tumor necrosis factor alpha-mediated apoptosis of human myometrial cells,” Biology of Reproduction, vol. 76, no. 5, pp. 769–776, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. J. Yui, M. Garcia-Lloret, T. G. Wegmann, and L. J. Guilbert, “Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts,” Placenta, vol. 15, no. 8, pp. 819–835, 1994. View at Publisher · View at Google Scholar · View at Scopus
  142. S. J. Fortunato and R. Menon, “IL-1β is a better inducer of apoptosis in human fetal membranes than IL-6,” Placenta, vol. 24, no. 10, pp. 922–928, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. R. Menon, S. J. Lombardi, and S. J. Fortunato, “TNF-α promotes caspase activation and apoptosis in human fetal membranes,” Journal of Assisted Reproduction and Genetics, vol. 19, no. 4, pp. 201–204, 2002. View at Publisher · View at Google Scholar · View at Scopus
  144. D. Kumar, W. Fung, R. M. Moore et al., “Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes,” Biology of Reproduction, vol. 74, no. 1, pp. 29–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  145. D. W. Sadowsky, K. M. Adams, M. G. Gravett, S. S. Witkin, and M. J. Novy, “Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a nonhuman primate model,” American Journal of Obstetrics and Gynecology, vol. 195, no. 6, pp. 1578–1589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  146. S. J. Fortunato, R. Menon, and S. J. Lombardi, “Interleukin-10 and transforming growth factor-β inhibit amniochorion tumor necrosis factor-α production by contrasting mechanisms of action: therapeutic implications in prematurity,” American Journal of Obstetrics and Gynecology, vol. 177, no. 4, pp. 803–809, 1997. View at Google Scholar · View at Scopus
  147. S. J. Fortunato, R. Menon, K. F. Swan, and S. J. Lombardi, “Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: transcriptional regulation,” American Journal of Obstetrics and Gynecology, vol. 175, no. 4, pp. 1057–1065, 1996. View at Publisher · View at Google Scholar · View at Scopus
  148. N. L. Brown, S. A. Alvi, M. G. Elder, P. R. Bennett, and M. H. F. Sullivan, “The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines,” Immunology, vol. 99, no. 1, pp. 124–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
  149. S. J. Fortunato, R. Menon, and S. J. Lombardi, “The effect of transforming growth factor and interleukin-10 on interleukin-8 release by human amniochorion may regulate histologic chorioamnionitis,” American Journal of Obstetrics and Gynecology, vol. 179, no. 3, pp. 794–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  150. J. A. Keelan, R. L. Zhou, and M. D. Mitchell, “Activin a exerts both pro- and anti-inflammatory effects on human term gestational tissues,” Placenta, vol. 21, no. 1, pp. 38–43, 2000. View at Publisher · View at Google Scholar · View at Scopus
  151. M. H. F. Sullivan, S. A. Alvi, N. L. Brown, M. G. Elder, and P. R. Bennett, “The effects of a cytokine suppressive anti-inflammatory drug on the output of prostaglandin E2 and interleukin-1β from human fetal membranes,” Molecular Human Reproduction, vol. 8, no. 3, pp. 281–285, 2002. View at Google Scholar · View at Scopus
  152. J. C. Lee and P. R. Young, “Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms,” Journal of Leukocyte Biology, vol. 59, no. 2, pp. 152–157, 1996. View at Google Scholar · View at Scopus
  153. N. Uchide, K. Ohyama, T. Bessho, and H. Toyoda, “Effects of mitogen-activated protein kinase inhibitors on tumor necrosis factor-α gene expression and apoptosis induction in cultured human fetal membrane chorion cells infected with influenza virus,” Intervirology, vol. 50, no. 2, pp. 99–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. D. De Silva, M. D. Mitchell, and J. A. Keelan, “Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-B kinase (IKK) inhibitors,” British Journal of Pharmacology, vol. 160, no. 7, pp. 1808–1822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. R. Hervé, T. Schmitz, D. Evain-Brion, D. Cabrol, M. J. Leroy, and C. Méhats, “The PDE4 inhibitor rolipram prevents NF-κB binding activity and proinflammatory cytokine release in human chorionic cells,” The Journal of Immunology, vol. 181, no. 3, pp. 2196–2202, 2008. View at Google Scholar · View at Scopus
  156. M. Lappas, M. Chai, G. E. Rice, and M. Permezel, “Cellular signalling pathways involved in the rupture of human fetal membranes,” in Molecular and Cell Biology in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 1–29, Research Signpost, Kerala, India, 2012. View at Google Scholar
  157. R. M. Moore, J. B. Novak, D. Kumar, J. M. Mansour, B. M. Mercer, and J. J. Moore, “Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of human fetal membranes,” Biology of Reproduction, vol. 80, no. 4, pp. 781–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. D. Kumar, F. Schatz, R. M. Moore et al., “The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro,” Placenta, vol. 32, no. 3, pp. 206–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  159. K. W. Marvin, J. A. Keelan, R. L. Eykholt, T. A. Sato, and M. D. Mitchell, “Use of cDNA array to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm,” Molecular Human Reproduction, vol. 8, no. 4, pp. 399–408, 2002. View at Google Scholar · View at Scopus
  160. M. H. F. Sullivan, K. Balachandran, A Boyce, and S. Tan, “Leukocyte invasion and activation,” in Molecular and Cell Biology in Rupture of Human Fetal Membranes, N. Uchide and H. Toyoda, Eds., pp. 119–132, Research Signpost, Kerala, India, 2012. View at Google Scholar
  161. B. J. Rollins, A. Walz, and M. Baggiolini, “Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes,” Blood, vol. 78, no. 4, pp. 1112–1116, 1991. View at Google Scholar · View at Scopus
  162. M. S. Esplin, R. Romero, T. Chaiworapongsa et al., “Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 17, no. 6, pp. 365–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  163. M. S. Esplin, M. R. Peltier, S. Hamblin et al., “Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor,” Placenta, vol. 26, no. 8-9, pp. 661–671, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. N. Athayde, R. Romero, E. Maymon et al., “A role for the novel cytokine RANTES in pregnancy and parturition,” American Journal of Obstetrics and Gynecology, vol. 181, no. 4, pp. 989–994, 1999. View at Publisher · View at Google Scholar · View at Scopus
  165. R. Romero, R. Gomez, M. Galasso et al., “Macrophage inflammatory protein-1α in term and preterm parturition: effect of microbial invasion of the amniotic cavity,” American Journal of Reproductive Immunology, vol. 32, no. 2, pp. 108–113, 1994. View at Google Scholar · View at Scopus
  166. D. J. Dudley, S. S. Edwin, A. Dangerfield, J. Van Waggoner, and M. D. Mitchell, “Regulation of cultured human chorion cell chemokine production by group B streptococci and purified bacterial products,” American Journal of Reproductive Immunology, vol. 36, no. 5, pp. 264–268, 1996. View at Google Scholar · View at Scopus
  167. D. J. Dudley, S. S. Edwin, and M. D. Mitchell, “Macrophage inflammatory protein-1α regulates prostaglandin E2 and interleukin-6 production by human gestational tissues in vitro,” Journal of the Society for Gynecologic Investigation, vol. 3, no. 1, pp. 12–16, 1996. View at Publisher · View at Google Scholar · View at Scopus
  168. H. Konishi, M. Nakatsuka, C. Chekir et al., “Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts,” Human Reproduction, vol. 19, no. 9, pp. 2156–2162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  169. N. J. Hannan, R. L. Jones, C. A. White, and L. A. Salamonsen, “The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface,” Biology of Reproduction, vol. 74, no. 5, pp. 896–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  170. R. Romero, M. Ceska, C. Avila, M. Mazor, E. Behnke, and I. Lindley, “Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition,” American Journal of Obstetrics and Gynecology, vol. 165, no. 4, pp. 813–820, 1991. View at Google Scholar · View at Scopus
  171. M. S. Trautman, D. J. Dudley, S. S. Edwin, D. Collmer, and M. D. Mitchell, “Amnion cell biosynthesis of interleukin-8: regulation by inflammatory cytokines,” Journal of Cellular Physiology, vol. 153, no. 1, pp. 38–43, 1992. View at Publisher · View at Google Scholar · View at Scopus
  172. A. Ito, T. Nakamura, T. Uchiyama et al., “Stimulation of the biosynthesis of interleukin 8 by interleukin 1 and tumor necrosis factor a in cultured human chorionic cells,” Biological and Pharmaceutical Bulletin, vol. 17, no. 11, pp. 1463–1467, 1994. View at Google Scholar · View at Scopus
  173. J. H. Hwang, M. J. Lee, O. S. Seok et al., “Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies,” Cytokine, vol. 49, no. 1, pp. 95–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  174. D. C. Lee, R. Romero, C. J. Kim et al., “Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy,” The Journal of Immunology, vol. 184, no. 11, pp. 6479–6491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. K. Kai, K. Nasu, S. Nakamura, J. Fukuda, M. Nishida, and I. Miyakawa, “Expression of interferon-γ-inducible protein-10 in human endometrial stromal cells,” Molecular Human Reproduction, vol. 8, no. 2, pp. 176–180, 2002. View at Google Scholar · View at Scopus
  176. F. Dominguez, S. Martínez, A. Quiñonero et al., “CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines,” Molecular Human Reproduction, vol. 14, no. 7, pp. 423–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  177. S. S. W. Chow, M. E. Craig, C. A. Jones et al., “Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection,” Cytokine, vol. 44, no. 1, pp. 78–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. N. Uchide, K. Ohyama, T. Bessho, and H. Toyoda, “Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells,” Intervirology, vol. 52, no. 3, pp. 164–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  179. N. Uchide, A. Suzuki, K. Ohyama, T. Bessho, and H. Toyoda, “Secretion of bioactive interleukin-6 and tumor necrosis factor-α proteins from primary cultured human fetal membrane chorion cells infected with influenza virus,” Placenta, vol. 27, no. 6-7, pp. 678–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  180. N. Uchide, K. Ohyama, T. Bessho, B. Yuan, and T. Yamakawa, “Apoptosis in cultured human fetal membrane cells infected with influenza virus,” Biological & pharmaceutical bulletin, vol. 25, no. 1, pp. 109–114, 2002. View at Google Scholar · View at Scopus
  181. Y. Gavrieli, Y. Sherman, and S. A. Ben-Sasson, “Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation,” Journal of Cell Biology, vol. 119, no. 3, pp. 493–501, 1992. View at Publisher · View at Google Scholar · View at Scopus
  182. N. Uchide, C. Tadera, H. Sarai, K. Ohyama, T. Bessho, and H. Toyoda, “Characterization of monocyte differentiation-inducing (MDI) factors derived from human fetal membrane chorion cells undergoing apoptosis after influenza virus infection,” The International Journal of Biochemistry and Cell Biology, vol. 38, no. 11, pp. 1926–1938, 2006. View at Publisher · View at Google Scholar · View at Scopus
  183. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, “Cell death: the significance of apoptosis,” International Review of Cytology, vol. 68, pp. 251–306, 1980. View at Google Scholar · View at Scopus
  184. S. K. Wray, B. E. Gilbert, M. W. Noall, and V. Knight, “Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis,” Antiviral Research, vol. 5, no. 1, pp. 29–37, 1985. View at Publisher · View at Google Scholar · View at Scopus
  185. N. Uchide, K. Ohyama, T. Bessho, and T. Yamakawa, “Semi-quantitative RT-PCR-based assay, improved by Southern hybridization technique, for polarity-specific influenza virus RNAs in cultured cells,” Journal of Virological Methods, vol. 106, no. 1, pp. 125–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  186. N. Uchide, K. Ohyama, T. Bessho, B. Yuan, and T. Yamakawa, “Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate,” Antiviral Research, vol. 56, no. 3, pp. 207–217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  187. N. Uchide and K. Ohyama, “Antiviral function of pyrrolidine dithiocarbamate against influenza virus: the inhibition of viral gene replication and transcription,” Journal of Antimicrobial Chemotherapy, vol. 52, no. 1, pp. 8–10, 2003. View at Google Scholar · View at Scopus
  188. N. Uchide, K. Ohyama, T. Bessho, and H. Toyoda, “Inhibition of influenza-virus-induced apoptosis in chorion cells of human fetal membranes by nordihydroguaiaretic acid,” Intervirology, vol. 48, no. 5, pp. 336–340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  189. S. J. Morris, G. E. Price, J. M. Barnett, S. A. Hiscox, H. Smith, and C. Sweet, “Role of neuraminidase in influenza virus-induced apoptosis,” Journal of General Virology, vol. 80, no. 1, pp. 137–146, 1999. View at Google Scholar · View at Scopus
  190. H. Fesq, M. Bacher, M. Nain, and D. Gemsa, “Programmed cell death (apoptosis) in human monocytes infected by influenza A virus,” Immunobiology, vol. 190, no. 1-2, pp. 175–182, 1994. View at Google Scholar · View at Scopus
  191. G. Kroemer, P. Petit, N. Zamzami, J. L. Vayssiere, and B. Mignotte, “The biochemistry of programmed cell death,” The FASEB Journal, vol. 9, no. 13, pp. 1277–1287, 1995. View at Google Scholar · View at Scopus
  192. Z. N. Oltvai and S. J. Korsmeyer, “Checkpoints of dueling dimers foil death wishes,” Cell, vol. 79, no. 2, pp. 189–192, 1994. View at Publisher · View at Google Scholar · View at Scopus
  193. S. Maruoka, S. Hashimoto, Y. Gon et al., “ASK1 regulates influenza virus infection-induced apoptotic cell death,” Biochemical and Biophysical Research Communications, vol. 307, no. 4, pp. 870–876, 2003. View at Publisher · View at Google Scholar · View at Scopus
  194. N. Uchide and H. Toyoda, “Significance of monocyte differentiation-inducing (MDI) factor in phagocytosis of apoptotic cells induced by influenza virus infection,” Current Topics in Virology, vol. 7, pp. 33–46, 2008. View at Google Scholar
  195. C. B. Thompson, “Apoptosis in the pathogenesis and treatment of disease,” Science, vol. 267, no. 5203, pp. 1456–1462, 1995. View at Google Scholar · View at Scopus
  196. I. Mori, T. Komatsu, K. Takeuchi, K. Nakakuki, M. Sudo, and Y. Kimura, “In vivo induction of apoptosis by influenza virus,” Journal of General Virology, vol. 76, no. 11, pp. 2869–2873, 1995. View at Google Scholar · View at Scopus
  197. R. Parnaik, M. C. Raff, and J. Scholes, “Differences between the clearance of apoptotic cells by professional and non-professional phagocytes,” Current Biology, vol. 10, no. 14, pp. 857–860, 2000. View at Publisher · View at Google Scholar · View at Scopus
  198. J. M. Hardwick, “Virus-Induced Apoptosis,” Advances in Pharmacology, vol. 41, pp. 295–336, 1997. View at Publisher · View at Google Scholar · View at Scopus
  199. L. S. Young, C. W. Dawson, and A. G. Eliopoulos, “Viruses and apoptosis,” British Medical Bulletin, vol. 53, no. 3, pp. 509–521, 1997. View at Google Scholar · View at Scopus
  200. Y. Watanabe, Y. Hashimoto, A. Shiratsuchi, T. Takizawa, and Y. Nakanishi, “Augmentation of fatality of influenza in mice by inhibition of phagocytosis,” Biochemical and Biophysical Research Communications, vol. 337, no. 3, pp. 881–886, 2005. View at Publisher · View at Google Scholar · View at Scopus
  201. M. L. Albert, B. Sauter, and N. Bhardwaj, “Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLS,” Nature, vol. 392, no. 6671, pp. 86–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  202. I. Fujimoto, J. Pan, T. Takizawa, and Y. Nakanishi, “Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages,” Journal of Virology, vol. 74, no. 7, pp. 3399–3403, 2000. View at Publisher · View at Google Scholar · View at Scopus
  203. I. Mori, F. Goshima, Y. Imai et al., “Olfactory receptor neurons prevent disseminations of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis,” Journal of General Virology, vol. 83, no. 9, pp. 2109–2116, 2002. View at Google Scholar · View at Scopus
  204. V. C. Huber, J. M. Lynch, D. J. Bucher, J. Le, and D. W. Metzger, “Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections,” The Journal of Immunology, vol. 166, no. 12, pp. 7381–7388, 2001. View at Google Scholar · View at Scopus
  205. C. Grimsley and K. S. Ravichandran, “Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals,” Trends in Cell Biology, vol. 13, no. 12, pp. 648–656, 2003. View at Publisher · View at Google Scholar · View at Scopus
  206. A. Shiratsuchi, M. Kaido, T. Takizawa, and Y. Nakanishi, “Phosphatidylserine-mediated phagocytosis of influenza A virus-infected cells by mouse peritoneal macrophages,” Journal of Virology, vol. 74, no. 19, pp. 9240–9244, 2000. View at Publisher · View at Google Scholar · View at Scopus
  207. Y. Watanabe, A. Shiratsuchi, K. Shimizu, T. Takizawa, and Y. Nakanishi, “Role of phosphatidylserine exposure and sugar chain desialylation at the surface of influenza virus-infected cells in efficient phagocytosis by macrophages,” The Journal of Biological Chemistry, vol. 277, no. 20, pp. 18222–18228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  208. Y. Watanabe, A. Shiratsuchi, K. Shimizu, T. Takizawa, and Y. Nakanishi, “Stimulation of phagocytosis of influenza virus-infected cells through surface desialylation of macrophages by viral neuraminidase,” Microbiology and Immunology, vol. 48, no. 11, pp. 875–881, 2004. View at Google Scholar · View at Scopus
  209. P. Hofmann, H. Sprenger, A. Kaufmann et al., “Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response,” Journal of Leukocyte Biology, vol. 61, no. 4, pp. 408–414, 1997. View at Google Scholar · View at Scopus
  210. M. Noda, K. Takeda, H. Sugimoto et al., “Purification and characterization of human fibroblast derived differentiation inducing factor for human monoblastic leukemia cells identical to interleukin-6,” Anticancer Research, vol. 11, no. 2, pp. 961–968, 1991. View at Google Scholar · View at Scopus
  211. K. Takeda, T. Hosoi, M. Noda, H. Arimura, and K. Konno, “Effect of fibroblast-derived differentiation inducing factor on the differentiation of human monocytoid and myeloid leukemia cell lines,” Biochemical and Biophysical Research Communications, vol. 155, no. 1, pp. 24–31, 1988. View at Google Scholar · View at Scopus
  212. N. Uchide, K. Ohyama, B. Yuan, T. Sano, T. Bessho, and T. Yamakawa, “Differential mRNA expression of inflammatory cytokines in cultured human fetal membrane cells responding to influenza virus infection,” Biological and Pharmaceutical Bulletin, vol. 25, no. 2, pp. 239–243, 2002. View at Publisher · View at Google Scholar · View at Scopus
  213. N. Uchide, K. Ohyama, B. Yuan, T. Bessho, and T. Yamakawa, “Differentiation of monocytes to macrophages induced by influenza virus-infected apoptotic cells,” Journal of General Virology, vol. 83, no. 4, pp. 747–751, 2002. View at Google Scholar · View at Scopus
  214. N. Uchide and H. Toyoda, “Molecular pathogenesis of influenza virus infection: apoptosis induction and macrophage activation,” in Cellular Signaling and Apoptosis Research, A. R. Demasi, Ed., pp. 91–128, Nova Science Publishers, New York, NY, USA, 2007. View at Google Scholar
  215. L. Peiser and S. Gordon, “The function of scavenger receptors expressed by macrophages and their rolein the regulation of inflammation,” Microbes and Infection, vol. 3, no. 2, pp. 149–159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  216. H. S. Liao, A. Matsumoto, H. Itakura, T. Pittman, T. Kodama, and Y. J. Geng, “De novo expression of the class-A macrophage scavenger receptor conferring resistance to apoptosis in differentiated human THP-1 monocytic cells,” Cell Death and Differentiation, vol. 6, no. 3, pp. 245–255, 1999. View at Google Scholar · View at Scopus
  217. R. Minakami and H. Sumimoto, “Phagocytosis-coupled activation of the superoxide-producing phagocyte oxidase, a member of the NADPH oxidase (Nox) family,” International Journal of Hematology, vol. 84, no. 3, pp. 193–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  218. P. E. Newburger, R. A. B. Ezekowitz, C. Whitney, J. Wright, and S. H. Orkin, “Induction of phagocyte cytochrome b heavy chain gene expression by interferon γ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 14, pp. 5215–5219, 1988. View at Google Scholar · View at Scopus
  219. N. P. Restifo, “Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity,” Current Opinion in Immunology, vol. 12, no. 5, pp. 597–603, 2000. View at Publisher · View at Google Scholar · View at Scopus
  220. H. Sprenger, R. G. Meyer, A. Kaufmann, D. Bußfeld, E. Rischkowsky, and D. Gemsa, “Selective induction of monocyte and not neurophil-attracting chemokines after influenza A virus infection,” Journal of Experimental Medicine, vol. 184, no. 3, pp. 1191–1196, 1996. View at Google Scholar · View at Scopus
  221. E. W. A. Brydon, H. Smith, and C. Sweet, “Influenza A virus-induced apoptosis in bronchiolar epithelial (NCl-H292) cells limits pro-inflammatory cytokine release,” Journal of General Virology, vol. 84, no. 9, pp. 2389–2400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  222. S. Matsukura, F. Kokubu, H. Noda, H. Tokunaga, and M. Adachi, “Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A,” The Journal of Allergy and Clinical Immunology, vol. 98, no. 6, pp. 1080–1087, 1996. View at Publisher · View at Google Scholar · View at Scopus
  223. T. Kishimoto, S. Akira, and T. Taga, “Interleukin-6 and its receptor: a paradigm for cytokines,” Science, vol. 258, no. 5082, pp. 593–597, 1992. View at Google Scholar · View at Scopus
  224. T. Taga, M. Hibi, Y. Hirata et al., “Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130,” Cell, vol. 58, no. 3, pp. 573–581, 1989. View at Google Scholar · View at Scopus
  225. W. K. Roberts and A. Vasil, “Evidence for the identity of murine gamma interferon and macrophage activating factor,” Journal of Interferon Research, vol. 2, no. 4, pp. 519–532, 1982. View at Google Scholar · View at Scopus
  226. D. L. Wiedbrauk and G. R. Burleson, “Production and characterization of poly(I):poly(C)-induced rat interferons in vitro,” Journal of Interferon Research, vol. 6, no. 3, pp. 281–295, 1986. View at Google Scholar · View at Scopus
  227. G. S. Vince and P. M. Johnson, “Leucocyte populations and cytokine regulation in human uteroplacental tissues,” Biochemical Society Transactions, vol. 28, no. 2, pp. 191–195, 2000. View at Google Scholar · View at Scopus
  228. D. M. Jenkins, M. O'Neill, and P. M. Johnson, “HLA-DR-positive cells in the human amniochorion,” Immunology Letters, vol. 6, no. 2, pp. 65–67, 1983. View at Publisher · View at Google Scholar · View at Scopus
  229. L. Sutton, D. Y. Mason, and C. W. G. Redman, “HLA-DR positive cells in the human placenta,” Immunology, vol. 49, no. 1, pp. 103–112, 1983. View at Google Scholar · View at Scopus
  230. L. Sutton, M. Gadd, D. Y. Mason, and C. W. G. Redman, “Cells bearing Class II MHC antigens in the human placenta and amniochorion,” Immunology, vol. 58, no. 1, pp. 23–29, 1986. View at Google Scholar · View at Scopus
  231. J. N. Bulmer and P. M. Johnson, “Macrophage populations in the human placenta and amniochorion,” Clinical and Experimental Immunology, vol. 57, no. 2, pp. 393–403, 1984. View at Google Scholar · View at Scopus
  232. J. N. Bulmer and P. M. Johnson, “Identification of leucocytes within the human chorion laeve,” Journal of Reproductive Immunology, vol. 7, no. 1, pp. 89–92, 1985. View at Publisher · View at Google Scholar · View at Scopus
  233. T. H. Hung, S. F. Chen, J. J. Hsu, C. C. Hsieh, S. Hsueh, and T. T. Hsieh, “Tumour necrosis factor-alpha converting enzyme in human gestational tissues from pregnancies complicated by chorioamnionitis,” Placenta, vol. 27, no. 9-10, pp. 996–1006, 2006. View at Publisher · View at Google Scholar · View at Scopus
  234. N. Uchide and H. Toyoda, “Virulence of influenza virus on human fetal membrane tissues,” in Infectious Pregnancy Complications, R. N. Canfield, Ed., pp. 111–138, Nova Science Publishers, New York, NY, USA, 2009. View at Google Scholar
  235. P. A. Baeuerle and T. Henkel, “Function and activation of NF-κB in the immune system,” Annual Review of Immunology, vol. 12, pp. 141–179, 1994. View at Google Scholar · View at Scopus
  236. P. A. Baeuerle and V. R. Baichwal, “NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules,” Advances in Immunology, vol. 65, pp. 111–137, 1997. View at Google Scholar · View at Scopus
  237. H. L. Pahl and P. A. Baeuerle, “Expression of influenza virus hemagglutinin activates transcription factor NF-κB,” Journal of Virology, vol. 69, no. 3, pp. 1480–1484, 1995. View at Google Scholar · View at Scopus
  238. E. Flory, M. Kunz, C. Scheller et al., “Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IκB kinase,” The Journal of Biological Chemistry, vol. 275, no. 12, pp. 8307–8314, 2000. View at Publisher · View at Google Scholar · View at Scopus
  239. P. Maderna and C. Godson, “Phagocytosis of apoptotic cells and the resolution of inflammation,” Biochimica et Biophysica Acta, vol. 1639, no. 3, pp. 141–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  240. J. B. Park, “Phagocytosis induces superoxide formation and apoptosis in macrophages,” Experimental and Molecular Medicine, vol. 35, no. 5, pp. 325–335, 2003. View at Google Scholar · View at Scopus
  241. M. S. Cohen, R. E. Isturiz, and H. L. Malech, “Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi,” The American Journal of Medicine, vol. 71, no. 1, pp. 59–66, 1981. View at Google Scholar · View at Scopus
  242. T. Oda, T. Akaike, T. Hamamoto, F. Suzuki, T. Hirano, and H. Maeda, “Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD,” Science, vol. 244, no. 4907, pp. 974–976, 1989. View at Google Scholar · View at Scopus
  243. H. B. Suliman, L. K. Ryan, L. Bishop, and R. J. Folz, “Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase,” American Journal of Physiology, vol. 280, no. 1, pp. L69–L78, 2001. View at Google Scholar · View at Scopus
  244. R. J. Snelgrove, L. Edwards, A. J. Rae, and T. Hussell, “An absence of reactive oxygen species improves the resolution of lung influenza infection,” European The Journal of Immunology, vol. 36, no. 6, pp. 1364–1373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  245. N. Uchide and H. Toyoda, “Current status of monocyte differentiation-inducing (MDI) factors derived from human fetal membrane chorion cells undergoing apoptosis after influenza virus infection,” Gene Regulation and Systems Biology, vol. 1, pp. 295–302, 2007. View at Google Scholar
  246. N. Uchide and H. Toyoda, “Potential of selected antioxidants for influenza chemotherapy,” Anti-Infective Agents in Medicinal Chemistry, vol. 7, no. 2, pp. 73–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  247. N. Uchide and H. Toyoda, “Future target molecules for influenza treatment,” Mini-Reviews in Medicinal Chemistry, vol. 8, no. 5, pp. 491–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  248. N. Uchide, K. Ohyama, and H. Toyoda, “Current and future anti-influenza virus drugs,” The Open Antimicrobial Agents Journal, vol. 2, no. 1, pp. 34–48, 2010. View at Google Scholar
  249. N. Uchide and H. Toyoda, “Antioxidant therapy as a potential approach to severe influenza-associated complications,” Molecules, vol. 16, no. 3, pp. 2032–2052, 2011. View at Publisher · View at Google Scholar · View at Scopus